Generics

Innovative Products found!

Biosimilars

Medical devices

Nutraceuticals

Filters

Pp-051.1 manufacturers

Filters

None products found

pp-051.1

Tablets, immediate release (IR)

Dossier type
US CTD
Dossier status
Under development
Country of origin
United States
GMP approvals
FDA
Comments
For moderate to severe acute pain, including post-surgical pain. Phase 3 global development, Small-molecule analgesic; Dual NOP/MOP receptor agonist (nociceptin and µ-opioid receptors). This first-in-class mechanism provides potent analgesia while potentially lowering risks associated with traditional opioids. Route / form: Oral immediate-release (IR) tablet. Differentiation: Provides opioid-level analgesia with a differentiated dual-receptor mechanism that may reduce respiratory depression, abuse potential, and other opioid-related safety concerns. Suitable for both acute pain and chronic pain programs.
Manufacturer #18873

A privately-held, mid-size biopharma firm focused on developing and marketing therapies for ADHD, pain, addiction and CNS disorders. It combines proprietary drug-delivery technology with global development and licensing efforts to deliver patient-friendly medications worldwide.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.